These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 18670432)
1. The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential. Lambert DG Nat Rev Drug Discov; 2008 Aug; 7(8):694-710. PubMed ID: 18670432 [TBL] [Abstract][Full Text] [Related]
2. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence. Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487 [TBL] [Abstract][Full Text] [Related]
3. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder. Zhang Y; Simpson-Durand CD; Standifer KM Br J Pharmacol; 2015 Jan; 172(2):571-82. PubMed ID: 24666365 [TBL] [Abstract][Full Text] [Related]
4. Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications. Chiou LC; Liao YY; Fan PC; Kuo PH; Wang CH; Riemer C; Prinssen EP Curr Drug Targets; 2007 Jan; 8(1):117-35. PubMed ID: 17266536 [TBL] [Abstract][Full Text] [Related]
5. Spotlight on Nociceptin/Orphanin FQ Receptor in the Treatment of Pain. El Daibani A; Che T Molecules; 2022 Jan; 27(3):. PubMed ID: 35163856 [TBL] [Abstract][Full Text] [Related]
6. Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy? Zeilhofer HU; Calò G J Pharmacol Exp Ther; 2003 Aug; 306(2):423-9. PubMed ID: 12721334 [TBL] [Abstract][Full Text] [Related]
7. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ. Donica CL; Awwad HO; Thakker DR; Standifer KM Mol Pharmacol; 2013 May; 83(5):907-18. PubMed ID: 23395957 [TBL] [Abstract][Full Text] [Related]
8. UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor. Calo G; Guerrini R; Rizzi A; Salvadori S; Burmeister M; Kapusta DR; Lambert DG; Regoli D CNS Drug Rev; 2005; 11(2):97-112. PubMed ID: 16007234 [TBL] [Abstract][Full Text] [Related]
9. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats. Micheli L; Di Cesare Mannelli L; Guerrini R; Trapella C; Zanardelli M; Ciccocioppo R; Rizzi A; Ghelardini C; Calò G Eur J Pharmacol; 2015 May; 754():73-81. PubMed ID: 25704616 [TBL] [Abstract][Full Text] [Related]
10. Recently patented and promising ORL-1 ligands: where have we been and where are we going? Largent-Milnes TM; Vanderah TW Expert Opin Ther Pat; 2010 Mar; 20(3):291-305. PubMed ID: 20180617 [TBL] [Abstract][Full Text] [Related]
11. Central N/OFQ-NOP Receptor System in Pain Modulation. Kiguchi N; Ding H; Ko MC Adv Pharmacol; 2016; 75():217-43. PubMed ID: 26920014 [TBL] [Abstract][Full Text] [Related]